All Stories

  1. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy
  2. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives
  3. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
  4. Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia
  5. PPAR-Alpha Agonists as Novel Antiepileptic Drugs: Preclinical Findings
  6. Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
  7. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats
  8. Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
  9. Novel Use of a Lipid-Lowering Fibrate Medication to Prevent Nicotine Reward and Relapse: Preclinical Findings
  10. Endocannabinoids and the Processing of Value-Related Signals
  11. Inhibitory Inputs from Rostromedial Tegmental Neurons Regulate Spontaneous Activity of Midbrain Dopamine Cells and Their Responses to Drugs of Abuse
  12. Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated Receptors
  13. Effects of Drugs of Abuse on Putative Rostromedial Tegmental Neurons, Inhibitory Afferents to Midbrain Dopamine Cells
  14. Peroxisome Proliferator-Activated Receptors-Alpha Modulate Dopamine Cell Activity Through Nicotinic Receptors
  15. The endocannabinoid system and nondrug rewarding behaviours
  16. PRECLINICAL STUDY: FULL ARTICLE: Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR‐α nuclear receptors
  17. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats
  18. Alcohol Inhibits Spontaneous Activity of Basolateral Amygdala Projection Neurons in the Rat: Involvement of the Endocannabinoid System
  19. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2
  20. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo
  21. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons
  22. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo
  23. Adolescent exposure to cannabinoids induces long-Lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons
  24. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions
  25. Characterization of wild-type (R100R) and mutated (Q100Q) GABAA α6 subunit in Sardinian alcohol non-preferring rats (sNP)
  26. Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study
  27. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study
  28. Stereoselectivity of NCS-382 binding to γ-hydroxybutyrate receptor in the rat brain
  29. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation
  30. General anaesthetic action at transmitter-gated inhibitory amino acid receptors
  31. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
  32. Complementary regulation of anaesthetic activation of human (α6β3γ2L) and Drosophila (RDL) GABA receptors by a single amino acid residue
  33. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor
  34. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study
  35. The Interaction of Intravenous Anesthetic Agents with Native and Recombinant GABAA Receptors
  36. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity
  37. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system
  38. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system
  39. Heterogeneous responses of substantia nigra pars reticulata neurons to γ-hydroxybutyric acid administration
  40. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats
  41. The GABA<sub>A</sub> Receptor: An Important Locus for Intravenous Anaesthetic Action